Thursday, 24 October 2019

Pharma News

  • Indian pharma clocks 8.9% growth in June 2013: IMS

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    New Delhi: The IMS Health Total Sales Audit (TSA) has released a report stating that the Indian pharmaceutical market has clocked a growth of 8.9 percent during the month of June 2013. The...Read more

  • Sanofi withdraws diabetes drug NDA in the US

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2013

    Singapore: Global pharmaceutical company, Sanofi has temporarily withdrawn new drug application (NDA) for lixisenatide in the US and plans to resubmit in 2015.Lixisenatide is approved in Eu...Read more

  • Antithrombotic drug market to be $24 bn by 2015

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2013

    Singapore: Visiongain, a business information provider, estimates in its report 'Antithrombotic Drugs: World Market 2013-2023' that the global antithrombotic drug market to reach revenue of...Read more

  • Ranbaxy advisory: All our products are safe and efficacious

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and efficacious. The firm revealed that the advisory was issued in public i...Read more

  • Amgen to acquire Onyx for $10 bn cash

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

    Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals for $125-per-share, totalling to $10.40 billion, in cash. The deal woul...Read more

  • Rabies claims 100 lives annually in Vietnam: UN

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

    Singapore: Vietnam has seen a substantial increase in the number of rabies fatalities from 34 deaths in 2003 to 131 deaths in 2007, according to United Nations (UN). World Rabies Day, whic...Read more

  • GSK Parkinson's drug can make you homosexual

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

    Singapore: A landmark appeal court ruling in Britain has ordered British drug giant GlaxoSmithKline (GSK) to provide compensation worth $256,384 (£160,000) to 52-year-old Mr Didier Jambart...Read more

  • QIAGEN reports 9% growth in Q2 2012

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2012

    Singapore: QIAGEN reported results of operations for the second quarter and first half of 2012, delivering a solid performance and making significant progress on strategic initiatives to dr...Read more

  • AstraZeneca makes initial payment of $3.2 billion to Amylin

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 10 Aug, 2012

    Singapore: Following the successful completion of the acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb, AstraZeneca has made an initial payment of approximately $3.2 billion to...Read more

  • Effient trial by Daiichi, Lilly fails to meet primary endpoint

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in patients with unstable angina (UA) or non-ST elevation myocardial infarct...Read more

  • Top 20: Singapore - High growth

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2014

    Singapore: Singapore has been witnessing strong performance. Here are a few developments in the country that are proof to increasing its bioscience presence. Alcon, global eye-care firm,...Read more

  • Now Ranbaxy's Mohali unit under FDA scanner

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2013

    Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, selling adulterated drugs in the US and paying a penalty of $500 millio...Read more

  • How are patent laws leading to the harmonizing effect?

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2013

    There have been recent changes to the US patent laws that have brought the US laws closer to those of the rest-of-the-world. You may have heard about some of them such as, changing the firs...Read more

  • Takeda ends 3-year-old-deal with Amylin

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

    Singapore: Takeda Pharmaceutical mutually terminated its worldwide agreement with Amylin Pharmaceuticals, which was originally signed in October 2009, to co-develop and commercialize compo...Read more

  • Bilcare to implement drug authentication project

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    Mumbai: The Council of Scientific and Industrial Research (CSIR), India, under its New Millennium Indian Technology Leadership Initiative (NMITLI) Scheme, has approved the implementation of...Read more

  • EMA committee positive on Teduglutide

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2012

    Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion for the medicinal product teduglutide (tradename in Euro...Read more

  • Marken opens pharma depot in Beijing

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Singapore: Marken announced the completion of its new pharmaceutical depot in Beijing, China. The new facility which provides 850 m2 of GMP compliant space for temperature controlled stora...Read more

  • FDA continues review of Crofelemer beyond goal date

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Mumbai: The Food and Drug Administration has advised Salix Pharmaceuticals, Mumbai-based Glenmark's collaborative partner, that the new drug application (NDA) for Crofelemer 125 mg tablets ...Read more



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls